Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
AUTHORS
Naguib
SSarah ,
DeJulius
CRCarlisle R ,
Backstrom
JRJon R ,
Haider
AAAmeer A ,
Ang
JMJohn M ,
Boal
AMAndrew M ,
Calkins
DJDavid J ,
Duvall
CLCraig L ,
Rex
TSTonia S .
Antioxidants (Basel, Switzerland). 2023 02 23; 12(3).
- PMID: 36978804[PubMed].